HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

Octagam

an intravenous IgG product for treating primary immunodeficiency diseases (PID)

Networked: 15 relevant articles (2 outcomes, 5 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1.	Wietek, Stefan: 2 articles (01/2018 - 11/2016)
2.	Debes, Anette: 2 articles (11/2016 - 09/2007)
3.	Moghadam-Kia, Siamak: 1 article (01/2022)
4.	Oddis, Chester V: 1 article (01/2022)
5.	Aggarwal, Rohit: 1 article (01/2021)
6.	Beckmann, Irene: 1 article (01/2021)
7.	Charles-Schoeman, Christina: 1 article (01/2021)
8.	Dimachkie, Mazen M: 1 article (01/2021)
9.	Levine, Todd: 1 article (01/2021)
10.	Schessl, Joachim: 1 article (01/2021)

Related Diseases

1.	Autoimmune Diseases (Autoimmune Disease) 09/01/2007 - "This study aimed to evaluate the long-term safety profile of Octagam in daily use in the treatment of various primary (PID) and secondary (SID) immunodeficiencies and autoimmune diseases (AID). " 11/01/2016 - "In autoimmune diseases, investigators assessed Octagam as being beneficial in 70% (immune thrombocytopenia) up to 100% (Guillain-Barré syndrome), depending on the indication. "
2.	Drug-Related Side Effects and Adverse Reactions 11/01/2016 - "Physicians used case report forms to document baseline demographics, Octagam treatment details, and data on the efficacy of Octagam, and recorded all adverse drug reactions (ADRs) and other safety data. "
3.	Guillain-Barre Syndrome 11/01/2016 - "In autoimmune diseases, investigators assessed Octagam as being beneficial in 70% (immune thrombocytopenia) up to 100% (Guillain-Barré syndrome), depending on the indication. "
4.	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 11/01/2016 - "In autoimmune diseases, investigators assessed Octagam as being beneficial in 70% (immune thrombocytopenia) up to 100% (Guillain-Barré syndrome), depending on the indication. "
5.	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 05/01/1996 - "In 22 chronic lymphocytic leukemia patients and 4 multiple myeloma patients, the monthly infusion of 0.4 gr/ kg Octagam proved safe and effective in increasing IgG levels and potentially reducing the rate of serious bacterial infections. "

Related Drugs and Biologics

1.	Immunoglobulin G (IgG)
2.	Inosine Triphosphate (ITP)
3.	Intravenous Immunoglobulins (IVIG)
4.	Biomarkers (Surrogate Marker)
5.	Steroids
6.	Adrenal Cortex Hormones (Corticosteroids)
7.	pentaglobulin
8.	sulfonated IgG

Related Therapies and Procedures

1.	Operative Surgical Procedures
2.	Therapeutics